Yin WJ - Search Results

1

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.

Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM. Yin WJ, et al. Breast Cancer Res Treat. 2009 May;115(2):325-33. doi: 10.1007/s10549-008-0096-0. Epub 2008 Jun 18. Breast Cancer Res Treat. 2009. PMID: 18563552

2

[Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine].

Fan J, Lu JS, Yin WJ, Lei W, Wu FY, Wu J, Hou YF, Li DQ, Di GH, Shen ZZ, Shao ZM. Fan J, et al. Among authors: yin wj. Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):886-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533736 Chinese.

3

[Clinico-pathological features of ER+/PR+ and ER+/PR- breast tumors: a comparative study of 5211 cases].

Zhou LH, Yin WJ, Lu JS, DI GH, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM. Zhou LH, et al. Among authors: yin wj. Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2764-7. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18167267 Chinese.

4

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.

Fan J, Yin WJ, Lu JS, Wang L, Wu J, Wu FY, Di GH, Shen ZZ, Shao ZM. Fan J, et al. Among authors: yin wj. J Cancer Res Clin Oncol. 2008 Aug;134(8):883-90. doi: 10.1007/s00432-008-0354-x. Epub 2008 Feb 9. J Cancer Res Clin Oncol. 2008. PMID: 18264725

5

Time-varying pattern of recurrence risk for Chinese breast cancer patients.

Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Yin W, et al. Breast Cancer Res Treat. 2009 Apr;114(3):527-35. doi: 10.1007/s10549-008-0022-5. Epub 2008 Apr 19. Breast Cancer Res Treat. 2009. PMID: 18425576

6

Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients.

Tang LC, Yin WJ, Di GH, Shen ZZ, Shao ZM. Tang LC, et al. Among authors: yin wj. Breast Cancer Res Treat. 2010 Jul;122(1):95-104. doi: 10.1007/s10549-009-0537-4. Epub 2009 Sep 17. Breast Cancer Res Treat. 2010. PMID: 19760032

7

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.

Lin Y, Yin W, Yan T, Zhou L, Di G, Wu J, Shen Z, Shao Z, Lu J. Lin Y, et al. BMC Cancer. 2009 Sep 24;9:342. doi: 10.1186/1471-2407-9-342. BMC Cancer. 2009. PMID: 19778431 Free PMC article.

8

Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer.

Cao AY, Hu Z, Yin WJ, Jin W, Shao ZM. Cao AY, et al. Among authors: yin wj. Breast Cancer Res Treat. 2010 May;121(1):247-9. doi: 10.1007/s10549-009-0629-1. Epub 2009 Nov 11. Breast Cancer Res Treat. 2010. PMID: 19904603 No abstract available.

9

Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population.

Cao AY, Yu KD, Yin WJ, Jin W, Di GH, Shen ZZ, Shao ZM. Cao AY, et al. Among authors: yin wj. Breast Cancer Res Treat. 2010 Aug;123(1):133-8. doi: 10.1007/s10549-009-0637-1. Epub 2009 Nov 18. Breast Cancer Res Treat. 2010. PMID: 19921424

10

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ, Wu J, Shao ZM. Jin W, et al. Among authors: yin wj. Breast Cancer Res Treat. 2010 Sep;123(2):359-73. doi: 10.1007/s10549-009-0652-2. Epub 2009 Nov 27. Breast Cancer Res Treat. 2010. PMID: 19943104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters